DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 210 filers reported holding DIPLOMAT PHARMACY INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $24,038,000 | -13.3% | 1,238,420 | +14.1% | 1.12% | -13.9% |
| Q2 2018 | $27,735,000 | +48.9% | 1,085,078 | +17.4% | 1.30% | +42.5% |
| Q1 2018 | $18,622,000 | -34.5% | 924,173 | -34.8% | 0.92% | -27.0% |
| Q4 2017 | $28,447,000 | -15.0% | 1,417,396 | -12.3% | 1.25% | -8.7% |
| Q3 2017 | $33,484,000 | +793.9% | 1,616,792 | +538.8% | 1.37% | +763.5% |
| Q2 2017 | $3,746,000 | – | 253,096 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |